Published on 16th January 2019


Weight and quality of diet may impact response to treatment for bipolar disorder, according to the findings of a clinical trial from the European College of Neuropsychopharmacology.

Presented at the ECNP Conference in Barcelona last year, the study showed that patients with a higher body mass index (BMI) and who ate foods that are thought to contribute to general inflammation did not respond as well to an add-on nutraceutical treatment. 

Pharmaceutical treatments for bipolar disorder (which used to be called manic depression), are better at targeting mania episodes rather than the depression that also accompanies the condition. However, the team of Australian, German and American scientists has shown that people who have a high-quality diet, a less inflammatory diet, and/or a low BMI may respond better to add-on nutraceutical treatment. Foods considered to be pro-inflammatory include those that are high in refined sugar and trans fats.


Read more articles and recipes